HLX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HLX is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading near short-term resistance in the pre-market, momentum is already extended, and the latest quarter showed weak profitability despite modest revenue growth. The merger with Hornbeck is the main event-driven catalyst, but the economics were described as underwhelming by analysts, so I would not treat this as an attractive immediate long-term entry. If forced to choose today, the better call is hold rather than buy.
HLX is in a short-term bullish trend: MACD histogram is positive and expanding, and moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200. However, RSI_6 is 82.823, which is strongly overbought, suggesting the current pre-market price around 10.29-10.35 is extended. Price is hovering just below/at R1 10.284 and below R2 10.636, with pivot at 9.715 and support at 9.146. That means upside exists, but the setup is not an attractive fresh entry for a patient long-term buyer right now.
["Helix announced a merger with Hornbeck Offshore Services, creating a strategic combination that can expand scale.", "Analysts recently raised the price target to $14 from $13 and kept a Buy rating.", "Revenue in Q1 2026 increased 3.55% YoY, showing top-line growth.", "MACD and moving averages remain bullish, supporting near-term momentum.", "Options flow is heavily call-biased, reflecting bullish trading sentiment."]
["TD Cowen said it was underwhelmed by the merger economics.", "Q1 2026 net income turned negative at -13.406M and EPS fell to -0.09.", "Gross margin dropped sharply to 3.07, indicating weaker profitability.", "RSI is overbought, which reduces attractiveness for a fresh entry.", "Hedge funds and insiders show no meaningful positive accumulation trend.", "No AI Stock Picker or SwingMax signal is present today."]
In Q1 2026, Helix posted revenue of 287.946M, up 3.55% year over year, which is a positive growth sign. However, profitability weakened sharply: net income fell to -13.406M, EPS declined to -0.09, and gross margin dropped to 3.07. The latest quarter season is Q1 2026, and the financial picture is mixed-to-weak because revenue grew but earnings and margins deteriorated.
Recent analyst sentiment is positive but measured. TD Cowen raised its price target twice, first to $13 from $12 and then to $14 from $13, while maintaining a Buy rating. The latest note acknowledged the strategic rationale of the Hornbeck merger but said the economics were underwhelming. Wall Street’s pro view is that Helix still generates solid free cash flow and has upside to a higher target; the con view is that 2026 guidance and merger economics leave less excitement than the Buy rating suggests.
